For hypertension, binding of the SARS-CoV-2 virus sarcomeric protein (S) to the cell surface angiotensin-converting enzyme 2 (ACE2) receptor mediates the entry of the virus into the cell, which results in a reduction in the amount of ACE2 and loss of ACE2 activity [68]. This evidence concerns the gene ACE2 and hypertensive disorder.